Chimerix, Inc.

[ILLUSTRATION OMITTED]

Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, has appointed Neil Frazer as its Chief Medical Officer. Prior to joining Chimerix, Dr Frazer served as the Chief Medical Officer and Chief Operating Officer of Erimos Pharmaceuticals (previously Biocure Medical) where he was responsible for the design of clinical drug development programs to meet US and global commercial, regulatory and scientific objectives. Prior to his tenure at Erimos, Dr Frazer served as the Vice President, Clinical Research at Shire Pharmaceuticals where he was responsible for clinical drug development of key programs that included Adderall XR, Equetro and Fosrenol. Dr Frazer obtained his BSc and medical degree from the University of Edinburgh Medical School.